Clinical Trial Results:
Estudio aleatorizado, multicéntrico, fase III, para estudiar la eficacia y seguridad de bevacizumab solo o en combinación con capecitabina y oxaliplatino, como terapia de mantenimiento, tras tratamiento inicial de quimioterapia con capecitabina, oxaliplatino y bevacizumab en pacientes con adenocarcinoma colorrectal metastásico
Summary
|
|
EudraCT number |
2005-003325-67 |
Trial protocol |
ES |
Global completion date |
08 Aug 2008
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
25 Jan 2019
|
First version publication date |
25 Jan 2019
|
Other versions |
|
Summary report(s) |
Publication_The Oncologist |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.